Synopsis
Synopsis
0
KDMF
0
VMF
0
API
0
FDF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Annual Reports
NA
1. 10,11 Dihydro-n,n,beta-trimethyl-5h-dibenz(b,f)azepine-5-propanamine
2. Apo Trimip
3. Apo-trimip
4. Apotrimip
5. Beta, Trimipramin
6. Eldoral
7. Herphonal
8. Novo Tripramine
9. Novo-tripramine
10. Novotripramine
11. Nu Trimipramine
12. Nu-trimipramine
13. Nutrimipramine
14. Rhotrimine
15. Stangyl
16. Surmontil
17. Surmontil Maleate
18. Trimeprimine
19. Trimidura
20. Trimineurin
21. Trimineurin Maleate
22. Trimipramin Azu
23. Trimipramin Beta
24. Trimipramin Neurazpharm
25. Trimipramin Stada
26. Trimipramin-neurazpharm
27. Trimipramine
28. Trimipramine Maleate (1:1)
29. Trimipramine Maleate (1:1), (+)-isomer
30. Trimipramine Maleate (1:1), (+-)-isomer
31. Trimipramine Maleate (1:1), (-)-isomer
32. Trimipramine Mesylate
33. Trimipramine Monohydrochloride
34. Trimipramine, (+-)-isomer
35. Trimipramine, (-)-isomer
36. Trimipraminneurazpharm
1. 521-78-8
2. Trimipramine Maleate Salt
3. Surmontil Maleate
4. Trimipramine (maleate)
5. Trimipramine Maleate, Bp
6. Trimipramine Hydrogen Maleate
7. Stangyl
8. (+)-trimipramine Maleate
9. (-)-trimipramine Maleate
10. Nsc-758386
11. Trimipramine Maleate, (+)-
12. Trimipramine Maleate, (-)-
13. 138283-61-1
14. 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-5h-dibenz(b,f)azepine Maleate (1:1)
15. 269k6498ld
16. D28e1043w5
17. Trimeprimine Maleate
18. I412286v22
19. Trimeprimine Monomaleate
20. Dsstox_cid_25315
21. Dsstox_rid_80796
22. Trimipramini Maleas
23. Dsstox_gsid_45315
24. (z)-but-2-enedioic Acid;3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-n,n,2-trimethylpropan-1-amine
25. 138283-60-0
26. Trimipramium Maleinicum
27. Trimipramine Acid Maleate
28. Chebi:35030
29. 10,11-dihydro-n,n,beta-trimethyl-5h-dibenz(b,f)azepine-5-propanamine (z)-2-butenedioate (1:1)
30. Sr-01000076152
31. Einecs 208-318-3
32. Unii-269k6498ld
33. Trimipraminemaleate
34. Surmontil (tn)
35. Prestwick_1022
36. Trimipramine Maleate [usan:usp:jan]
37. Trimipraminhydrogenmaleat
38. 3-(10,11-dihydro-5h-dibenzo[b,f]azepin-5-yl)-n,n,2-trimethylpropan-1-amine Maleate
39. Ncgc00016483-01
40. Cas-521-78-8
41. Schembl41289
42. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,beta-trimethyl-, (z)-2-butenedioate (1:1)
43. Mls001056765
44. Spectrum1503117
45. Chembl1200948
46. Dtxsid2045315
47. Unii-d28e1043w5
48. Hms500e15
49. Trimipramine Maleate (jan/usp)
50. Trimipramine Maleate [mi]
51. Hms1570b13
52. Hms1922g07
53. Hms2092l08
54. Hms2097b13
55. Hms2233h17
56. Hms3263h13
57. Hms3714b13
58. Pharmakon1600-01503117
59. Trimipramine Maleate [jan]
60. Unii-i412286v22
61. Trimipramine Maleate [usan]
62. Hy-b1213
63. Trimipramine For Peak Identification
64. Tox21_110449
65. Tox21_501156
66. Trimipramine Maleate [vandf]
67. Ccg-39308
68. Nsc758386
69. Trimipramine Maleate [mart.]
70. Trimipramine Maleate [usp-rs]
71. Trimipramine Maleate [who-dd]
72. Akos026750012
73. Tox21_110449_1
74. Cs-4840
75. Lp01156
76. Nsc 758386
77. 5h-dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-, Maleate (1:1)
78. Ncgc00016013-06
79. Ncgc00094418-01
80. Ncgc00094418-02
81. Ncgc00094418-03
82. Ncgc00094418-04
83. Ncgc00094418-05
84. Ncgc00261841-01
85. 1217260-65-5
86. Bs-17213
87. Smr000326720
88. Trimipramine Maleate [orange Book]
89. Trimipramine Maleate [ep Monograph]
90. Trimipramine Maleate [usp Monograph]
91. Eu-0101156
92. Sw197096-3
93. D02408
94. T 3146
95. Sr-01000076152-1
96. Sr-01000076152-4
97. Sr-01000076152-6
98. Q27116374
99. Trimipramine Maleate 1.0 Mg/ml In Methanol (as Free Base)
100. 10,11-dihydro-n,n,beta-trimethyl-5h-dibenz[b,f]azepine-5-propanamine(2z)-2-butenedioate
101. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,.beta.-trimethyl-, (+)-, (2z)-2-butenedioate (1:1)
102. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,.beta.-trimethyl-, (+)-, (z)-2-butenedioate (1:1)
103. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,.beta.-trimethyl-, (-)-, (2z)-2-butenedioate (1:1)
104. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,.beta.-trimethyl-, (-)-, (z)-2-butenedioate (1:1)
105. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,.beta.-trimethyl-, (z)-2-butenedioate (1:1)
106. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,beta-trimethyl-, (+)-, (2z)-2-butenedioate (1:1)
107. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,beta-trimethyl-, (+)-, (z)-2-butenedioate (1:1)
108. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,beta-trimethyl-, (-)-, (2z)-2-butenedioate (1:1)
109. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,beta-trimethyl-, (-)-, (z)-2-butenedioate (1:1)
110. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n,beta-trimethyl-, (2z)-2-butenedioate (1:1)
Molecular Weight | 410.5 g/mol |
---|---|
Molecular Formula | C24H30N2O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 410.22055744 g/mol |
Monoisotopic Mass | 410.22055744 g/mol |
Topological Polar Surface Area | 81.1 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 436 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Surmontil |
PubMed Health | Trimipramine (By mouth) |
Drug Classes | Antidepreant |
Drug Label | SURMONTIL (trimipramine maleate) is 5-(3-dimethylamino-2-methylpropyl)-10,11-dihydro-5H-dibenz (b,f) azepine acid maleate (racemic form). Molecular Formula: C20H26N2 C4H4O4 Molecular Weight: 410.5SURMONTIL capsules contain trimipramine maleate eq... |
Active Ingredient | Trimipramine maleate |
Dosage Form | Capsule |
Route | Oral |
Strength | eq 100mg base; eq 50mg base; eq 25mg base |
Market Status | Prescription |
Company | Odyey Pharms |
2 of 4 | |
---|---|
Drug Name | Trimipramine maleate |
Drug Label | Trimipramine maleate is 5-(3-dimethylamino-2-methylpropyl)-10, 11-dihydro-5H-dibenz (b,f) azepine acid maleate (racemic form). Molecular Formula: C20H26N2 C4H4O4 Molecular Weight: 410.5Trimipramine maleate capsules contain tr... |
Active Ingredient | Trimipramine maleate |
Dosage Form | Capsule |
Route | Oral |
Strength | eq 100mg base; eq 50mg base; eq 25mg base |
Market Status | Prescription |
Company | Mikah Pharma |
3 of 4 | |
---|---|
Drug Name | Surmontil |
PubMed Health | Trimipramine (By mouth) |
Drug Classes | Antidepreant |
Drug Label | SURMONTIL (trimipramine maleate) is 5-(3-dimethylamino-2-methylpropyl)-10,11-dihydro-5H-dibenz (b,f) azepine acid maleate (racemic form). Molecular Formula: C20H26N2 C4H4O4 Molecular Weight: 410.5SURMONTIL capsules contain trimipramine maleate eq... |
Active Ingredient | Trimipramine maleate |
Dosage Form | Capsule |
Route | Oral |
Strength | eq 100mg base; eq 50mg base; eq 25mg base |
Market Status | Prescription |
Company | Odyey Pharms |
4 of 4 | |
---|---|
Drug Name | Trimipramine maleate |
Drug Label | Trimipramine maleate is 5-(3-dimethylamino-2-methylpropyl)-10, 11-dihydro-5H-dibenz (b,f) azepine acid maleate (racemic form). Molecular Formula: C20H26N2 C4H4O4 Molecular Weight: 410.5Trimipramine maleate capsules contain tr... |
Active Ingredient | Trimipramine maleate |
Dosage Form | Capsule |
Route | Oral |
Strength | eq 100mg base; eq 50mg base; eq 25mg base |
Market Status | Prescription |
Company | Mikah Pharma |
Antidepressive Agents, Tricyclic
Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)
Adrenergic Uptake Inhibitors
Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)
Registration Number : 220MF10195
Registrant's Address : 82 Avenue Raspail 94250 Gentilly France
Initial Date of Registration : 2008-08-28
Latest Date of Registration : --
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4078
Submission : 1981-02-18
Status : Inactive
Type : II
Certificate Number : CEP 2003-121 - Rev 04
Issue Date : 2024-02-02
Type : Chemical
Substance Number : 534
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17665
Submission : 2004-09-10
Status : Inactive
Type : II
Certificate Number : R0-CEP 2005-075 - Rev 00
Issue Date : 2009-10-05
Type : Chemical
Substance Number : 534
Status : Withdrawn by Holder
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-23
Pay. Date : 2013-02-21
DMF Number : 5900
Submission : 1985-04-22
Status : Active
Type : II
Certificate Number : R1-CEP 2011-329 - Rev 00
Issue Date : 2018-01-24
Type : Chemical
Substance Number : 534
Status : Valid
NDC Package Code : 45562-1739
Start Marketing Date : 2012-07-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Date of Issue : 2019-08-05
Valid Till : 2022-07-21
Written Confirmation Number : WC-0139A3
Address of the Firm :
Date of Issue : 2021-08-06
Valid Till : 2022-07-28
Written Confirmation Number : WC-0445A4
Address of the Firm :
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Trimipramine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trimipramine, including repackagers and relabelers. The FDA regulates Trimipramine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trimipramine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trimipramine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trimipramine supplier is an individual or a company that provides Trimipramine active pharmaceutical ingredient (API) or Trimipramine finished formulations upon request. The Trimipramine suppliers may include Trimipramine API manufacturers, exporters, distributors and traders.
click here to find a list of Trimipramine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trimipramine DMF (Drug Master File) is a document detailing the whole manufacturing process of Trimipramine active pharmaceutical ingredient (API) in detail. Different forms of Trimipramine DMFs exist exist since differing nations have different regulations, such as Trimipramine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trimipramine DMF submitted to regulatory agencies in the US is known as a USDMF. Trimipramine USDMF includes data on Trimipramine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trimipramine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trimipramine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Trimipramine Drug Master File in Japan (Trimipramine JDMF) empowers Trimipramine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Trimipramine JDMF during the approval evaluation for pharmaceutical products. At the time of Trimipramine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Trimipramine suppliers with JDMF on PharmaCompass.
A Trimipramine CEP of the European Pharmacopoeia monograph is often referred to as a Trimipramine Certificate of Suitability (COS). The purpose of a Trimipramine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Trimipramine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Trimipramine to their clients by showing that a Trimipramine CEP has been issued for it. The manufacturer submits a Trimipramine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Trimipramine CEP holder for the record. Additionally, the data presented in the Trimipramine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Trimipramine DMF.
A Trimipramine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Trimipramine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Trimipramine suppliers with CEP (COS) on PharmaCompass.
A Trimipramine written confirmation (Trimipramine WC) is an official document issued by a regulatory agency to a Trimipramine manufacturer, verifying that the manufacturing facility of a Trimipramine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trimipramine APIs or Trimipramine finished pharmaceutical products to another nation, regulatory agencies frequently require a Trimipramine WC (written confirmation) as part of the regulatory process.
click here to find a list of Trimipramine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trimipramine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trimipramine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trimipramine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trimipramine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trimipramine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trimipramine suppliers with NDC on PharmaCompass.
Trimipramine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trimipramine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trimipramine GMP manufacturer or Trimipramine GMP API supplier for your needs.
A Trimipramine CoA (Certificate of Analysis) is a formal document that attests to Trimipramine's compliance with Trimipramine specifications and serves as a tool for batch-level quality control.
Trimipramine CoA mostly includes findings from lab analyses of a specific batch. For each Trimipramine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trimipramine may be tested according to a variety of international standards, such as European Pharmacopoeia (Trimipramine EP), Trimipramine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trimipramine USP).
LOOKING FOR A SUPPLIER?